重组Anti-GRID2抗体[EPR15422] - N-terminal
Anti-GRID2 antibody [EPR15422] - N-terminal
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal GRID2 antibody. N-terminal. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 4 publications.
查看别名
GLURD2, GRID2, GluD2, GluR delta-2 subunit
- WB
Supplier Data
Western blot - Anti-GRID2 antibody [EPR15422] - N-terminal (AB198499)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-GRID2 antibody [EPR15422] - N-terminal (ab198499) at 1/50000 dilution
All lanes:
Human cerebellum lysate (boiled) at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 113 kDa
Observed band size: 113 kDa
false
Exposure time: 20s
- WB
Supplier Data
Western blot - Anti-GRID2 antibody [EPR15422] - N-terminal (AB198499)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-GRID2 antibody [EPR15422] - N-terminal (ab198499) at 1/5000 dilution
Lane 1:
Mouse brain lysate (boiled) at 20 µg
Lane 2:
Mouse brain lysate at 20 µg
Lane 3:
Rat brain lysate (boiled) at 20 µg
Lane 4:
Rat brain lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 113 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-GRID2 antibody [EPR15422] - N-terminal (AB198499)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-GRID2 antibody [EPR15422] - N-terminal (ab198499) at 1/5000 dilution
All lanes:
HeLa cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 113 kDa
Observed band size: 113 kDa
true
Exposure time: 3min
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The GRID2 protein is significant in synaptic plasticity and cerebellar functions by contributing to synapse formation and stability. It is part of the postsynaptic density (PSD) complex in neurons mainly affecting the communication between neuron cells. This protein helps in maintaining proper synaptic connections necessary for motor coordination and learning. The deficit of GRID2 can disrupt these functions affecting synaptic efficacy and neurological behavior.
Pathways
Grid ionotropic receptors like GRID2 play a pivotal role in the glutamatergic pathway and the synaptic signaling pathway. These pathways have strong associations with synaptic transmission and plasticity influencing learning and memory. The relationship of GRID2 with other proteins such as GRIA1 another glutamate receptor highlights its involvement in regulating synaptic strength and communication between neurons.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (4)
Recent publications for all applications. Explore the full list and refine your search
Neuron 112:362-383.e15 PubMed38016472
2023
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 120:e2219897120 PubMed37459550
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioscience reports 41: PubMed33969375
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 17:1863-1869 PubMed30783461
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com